180 related articles for article (PubMed ID: 16154771)
1. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.
Deberg MA; Labasse AH; Collette J; Seidel L; Reginster JY; Henrotin YE
Osteoarthritis Cartilage; 2005 Dec; 13(12):1059-65. PubMed ID: 16154771
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.
Bruyere O; Collette JH; Ethgen O; Rovati LC; Giacovelli G; Henrotin YE; Seidel L; Reginster JY
J Rheumatol; 2003 May; 30(5):1043-50. PubMed ID: 12734904
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
4. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
5. Type II collagen peptides for measuring cartilage degradation.
Henrotin Y; Deberg M; Dubuc JE; Quettier E; Christgau S; Reginster JY
Biorheology; 2004; 41(3-4):543-7. PubMed ID: 15299285
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary type II collagen C-telopeptide levels in Tunisian patients with knee osteoarthritis.
Kalai E; Bahlous A; Charni N; Bouzid K; Sahli H; Chelly M; Meddeb M; Zouari B; Abdelmoula J; Sellami S
Clin Lab; 2012; 58(3-4):209-15. PubMed ID: 22582493
[TBL] [Abstract][Full Text] [Related]
7. Rapid Progression of Knee Pain and Osteoarthritis Biomarkers Greatest for Patients with Combined Obesity and Depression: Data from the Osteoarthritis Initiative.
Jacobs CA; Vranceanu AM; Thompson KL; Lattermann C
Cartilage; 2020 Jan; 11(1):38-46. PubMed ID: 29855190
[TBL] [Abstract][Full Text] [Related]
8. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
9. Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
Klocke R; Levasseur K; Kitas GD; Smith JP; Hirsch G
Rheumatol Int; 2018 Mar; 38(3):455-459. PubMed ID: 29396701
[TBL] [Abstract][Full Text] [Related]
10. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey.
Tanishi N; Yamagiwa H; Hayami T; Mera H; Koga Y; Omori G; Endo N
J Orthop Sci; 2014 May; 19(3):429-36. PubMed ID: 24504986
[TBL] [Abstract][Full Text] [Related]
12. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.
Kumm J; Tamm A; Lintrop M; Tamm A
Rheumatol Int; 2013 Apr; 33(4):903-11. PubMed ID: 22821260
[TBL] [Abstract][Full Text] [Related]
13. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.
Van Spil WE; Welsing PM; Bierma-Zeinstra SM; Bijlsma JW; Roorda LD; Cats HA; Lafeber FP
Osteoarthritis Cartilage; 2015 Aug; 23(8):1388-97. PubMed ID: 25819579
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
Dam EB; Byrjalsen I; Karsdal MA; Qvist P; Christiansen C
Osteoarthritis Cartilage; 2009 Mar; 17(3):384-9. PubMed ID: 18768336
[TBL] [Abstract][Full Text] [Related]
15. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.
Raynauld JP; Martel-Pelletier J; Berthiaume MJ; Beaudoin G; Choquette D; Haraoui B; Tannenbaum H; Meyer JM; Beary JF; Cline GA; Pelletier JP
Arthritis Res Ther; 2006; 8(1):R21. PubMed ID: 16507119
[TBL] [Abstract][Full Text] [Related]
16. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
Garnero P; Aronstein WS; Cohen SB; Conaghan PG; Cline GA; Christiansen C; Beary JF; Meyer JM; Bingham CO
Osteoarthritis Cartilage; 2008 Jun; 16(6):660-6. PubMed ID: 17993283
[TBL] [Abstract][Full Text] [Related]
17. Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis.
Hellio Le Graverand MP; Brandt KD; Mazzuca SA; Katz BP; Buck R; Lane KA; Pickering E; Nemirovskiy OV; Sunyer T; Welsch DJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1189-95. PubMed ID: 16753310
[TBL] [Abstract][Full Text] [Related]
18. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
[TBL] [Abstract][Full Text] [Related]
19. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease.
Wang B; Pramono HK; Cicuttini FM; Hanna F; Davis SR; Bell RJ; Wang Y
Osteoarthritis Cartilage; 2014 Aug; 22(8):1136-41. PubMed ID: 24971869
[TBL] [Abstract][Full Text] [Related]
20. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
